Cross Staff Investments Inc acquired a new position in shares of The Allstate Co. (NYSE:ALL – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,500 shares of the insurance provider’s stock, valued at approximately $210,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in Allstate in the 3rd quarter valued at $25,000. Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Allstate in the 4th quarter worth about $36,000. Venturi Wealth Management LLC lifted its position in Allstate by 152.7% in the 4th quarter. Venturi Wealth Management LLC now owns 278 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 168 shares in the last quarter. Bruce G. Allen Investments LLC acquired a new position in Allstate during the 4th quarter valued at about $43,000. Finally, Planned Solutions Inc. purchased a new stake in shares of Allstate in the fourth quarter worth approximately $53,000. Institutional investors and hedge funds own 76.47% of the company’s stock.
Allstate Price Performance
ALL traded down $2.33 on Friday, hitting $170.01. The company’s stock had a trading volume of 854,323 shares, compared to its average volume of 1,675,038. The company’s 50 day simple moving average is $164.92 and its 200-day simple moving average is $148.75. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.51. The Allstate Co. has a 12 month low of $100.57 and a 12 month high of $176.93.
Allstate Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Monday, March 4th were paid a $0.92 dividend. The ex-dividend date was Friday, March 1st. This is a boost from Allstate’s previous quarterly dividend of $0.89. This represents a $3.68 annualized dividend and a yield of 2.16%. Allstate’s dividend payout ratio is currently -296.77%.
Insider Buying and Selling at Allstate
In related news, CAO John C. Pintozzi sold 4,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,736 shares in the company, valued at $1,712,069.92. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the sale, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the transaction, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The disclosure for this sale can be found here. Insiders own 1.80% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on ALL shares. Piper Sandler upped their price target on Allstate from $172.00 to $188.00 and gave the stock an “overweight” rating in a report on Monday, April 1st. Morgan Stanley raised their price target on shares of Allstate from $187.00 to $190.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. BMO Capital Markets increased their price objective on shares of Allstate from $140.00 to $158.00 and gave the company a “market perform” rating in a research note on Friday, January 19th. Evercore ISI boosted their target price on Allstate from $166.00 to $173.00 and gave the stock an “in-line” rating in a research note on Thursday, April 11th. Finally, Roth Mkm upped their target price on Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a report on Monday, April 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $173.71.
Get Our Latest Report on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Ride Out The Recession With These Dividend KingsĀ
- 3 Stocks Leading the U.S. Agriculture Comeback
- What to Know About Investing in Penny Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What is the S&P 500 and How It is Distinct from Other Indexes
- Alphabet Changes the Narrative with Its First-Ever Dividend
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.